|
HS Code |
677143 |
| Chemical Name | 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate |
| Molecular Formula | C22H25ClN2O6 |
| Molecular Weight | 448.89 g/mol |
| Appearance | White to off-white solid |
| Solubility | Soluble in DMSO and methanol |
| Purity | Typically ≥98% |
| Cas Number | 147328-19-0 |
| Storage Temperature | 2-8°C |
| Optical Rotation | [α]20/D +22° (c=1, H2O) |
| Synonyms | Desmethylolanzapine L-Tartrate |
| Melting Point | Approximately 156-160°C |
| Application | Pharmaceutical intermediate |
As an accredited 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25g of 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate, sealed with a tamper-evident cap. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with sealed bags/drums of 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate, securely palletized, moisture-protected. |
| Shipping | The chemical **2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate** is shipped in a tightly sealed, inert container, with appropriate labeling and documentation. It is packaged to prevent moisture and light exposure, and dispatched via certified carriers under controlled temperature conditions, in compliance with all relevant chemical safety and transport regulations. |
| Storage | Store **2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-tartrate** in a cool, dry, and well-ventilated area, away from direct sunlight and moisture. Keep the container tightly closed when not in use. Store at 2-8°C (refrigerator) for optimal stability. Avoid exposure to incompatible substances, such as strong oxidizers. Ensure appropriate labeling and access only to authorized personnel. |
| Shelf Life | Shelf life: Store 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-tartrate at 2-8°C; stable for 2 years, protected from light. |
|
Purity 98%: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with purity 98% is used in pharmaceutical synthesis, where it ensures high yield and minimized impurities in the final active ingredient. Melting point 175–179°C: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with a melting point of 175–179°C is used in solid-state formulation development, where it provides thermal stability during processing. Chirality (S-enantiomer > 99% ee): 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with S-enantiomer excess above 99% is used in enantioselective drug design, where it enhances target receptor specificity and pharmacological efficacy. Molecular weight 496.96 g/mol: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with a molecular weight of 496.96 g/mol is used in receptor binding studies, where it allows precise dosing and accurate pharmacokinetic profiling. Solubility in water 10 mg/mL: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with water solubility of 10 mg/mL is used in injectable solution formulations, where it ensures rapid bioavailability and consistent therapeutic action. Stability at 25°C: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with stability at 25°C is used in room temperature storage applications, where it maintains chemical integrity and prolongs shelf-life. Particle size D90 < 75 µm: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with particle size D90 under 75 µm is used in oral tablet manufacturing, where it promotes uniform mixing and optimal dissolution rates. Residual solvent < 0.1%: 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate with residual solvent below 0.1% is used in safety-sensitive pharmaceutical products, where it ensures compliance with toxicity limits and regulatory standards. Stability in acidic media (pH 2): 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate stable in acidic media at pH 2 is used in gastro-resistant formulations, where it prevents degradation in the stomach and enhances therapeutic efficacy. |
Competitive 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the driven world of fine chemicals, decisions rest on purity, reliability, and openly transparent manufacturing. At our manufacturing facility, the creation of 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate stands as a result of steady focus, material traceability, and hands-on technical stewardship. Our team engineers every batch from the synthesis of intermediates to the nuanced resolution of the enantiomeric tartrate salt, anchoring the consistency needed for demanding pharmaceutical and advanced research applications.
We've seen that subtle differences in raw material origin, process water, and handling mean everything for reproducibility during scale-up and analytical validation. By controlling each stage from the ground up, we've gained insight into the minute adjustments that distinguish a truly trustworthy laboratory reagent from an unpredictable mixture. Customers depend on this stability because the work downstream—basic pharmacology, API synthesis, or method development—rewards certainty and penalizes noise or variability.
Due to its chiral nature, 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate demands sharp attention to isomeric purity alongside chemical purity. Many suppliers gravitate to quick fixes or bulk intermediates, but our background in asymmetric chemistry leads us to pursue thorough resolution and controlled crystallisation, not only for compliance but for proven reproducibility in pharmaceutical experimentation. Chiral chromatography, NMR, and mass spectrometry all confirm the identity and ratio of enantiomers in our product, minimizing regulatory questions and troubleshooting on the researcher’s part.
Manufacturing 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate is not a rote task. In our experience, standard synthesis can expose a project to hydrolysis, side reactions, or loss of activity through mishandling. We've resolved these challenges, and our teams have learned to preemptively monitor for by-products that others only find after the fact. Every kilo reflects a disciplined attitude developed over years on the production floor, from keeping glassware immaculate to working with solvents graded to stringent standards.
Our process starts with careful selection of starting amines, piperidines, and aromatic chlorides. Each lot runs through a set of synthetic steps optimized to reduce impurity formation and to optimize final yield. The importance of solvent choice becomes clear here. Crude product is navigated through preparative purification, then isolated precisely as the L-tartrate salt to secure desired enantiomeric purity and enhanced solubility. Moisture, light, and temperature each shape outcome, so parameters are woven into batch records as routine data, not vague guidelines.
The crystalline tartrate that we deliver allows end-users to handle the product with ease, weighing, dissolving, and storing samples without degradation. From our vantage, careful drying, sieving, and controlled packing often dictate how smoothly later blending, dosing, and analytical weighing will proceed in the customer’s laboratory.
Customers often ask why one producer’s material performs better than another’s. We've learned that the story goes much deeper than formularies or published specs. The batch-to-batch consistency is traced to in-process controls and the very people behind the process. By monitoring key parameters at each stage, we've ensured that even as lots scale from grams to kilograms, the purity profile and particle morphology remain tightly controlled.
Analytical data reflect not just official values for assay and enantiomeric excess but also absence of critical process impurities and verified moisture content. No two chemist’s requests are exactly the same. Some demand documentation for elemental impurities or residual solvents following ICH guidelines, and our in-house capabilities cover these needs through ICP-MS and GC analysis.
One clear difference in our product reflects attention to downstream use: predictable dissolution times and particle behavior in different solvents, not just in water but in acetonitrile, methanol, or buffered media. Unlike poorly crystallized salts that refuse to dissolve or leave particulate matter, our product delivers transparency crucial for analytical and synthetic workflows. This attention to real laboratory conditions, shaped by conversations and feedback from hundreds of customers, has inspired continuous process refinement.
We approve every lot based on validated methods, not just for regulatory agencies but to address foreseeable issues—whether it’s baseline spikes in LC-MS, variance in NMR, or minor color impurities that reveal over-oxidation or carryover. These may sound minor, yet every time a researcher must repeat a synthesis or rerun an analysis because of unreliable material, hidden costs pile up. Our own teams have faced these frustrations before, so quality assurance means standing in the user’s shoes.
2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate serves as more than just a catalog entry. Researchers in medicinal chemistry turn to this intermediate in the synthesis of novel bioactive compounds, particularly where precise stereochemistry plays a key role in functional outcomes. In our interactions with pharmaceutical teams, we've seen it serve as a scaffold for CNS-active agents, with the stereoisomer dictating potency or selectivity.
Diagnostics labs exploring receptor-ligand interactions have relied on the stability and clarity of our lots to generate reproducible data sets. Pharmacologists exploring therapeutic potential see fewer ambiguous results when starting with our well-characterized product. Even in academic environments, faculty and postdocs appreciate an openly documented analytical file, allowing them to publish with confidence and survive the scrutiny of peer review and grant renewals.
Custom synthesis projects occasionally surface requiring modification of functional groups or salt forms. Our direct control over synthetic steps and raw materials grants us unique flexibility for these tailored projects. Flexibility does not mean dilution of standards. We’ve been tasked with preparing labeled analogs, deuterated variants, or simply kilogram quantities with altered impurity profiles for tox studies. Our documentation trails cover every fork in the production path.
In formulation research, the tartrate salt often supplies improved solubility or modified pharmacokinetics over alternative salt forms, sparing time and resources in early screening. By directly collecting feedback from formulation scientists who test our salt against others, we learn where benefits arise, such as reduced clogging in process lines, cleaner filters, and lower batch rejections.
Supplying 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate at scale has taught us lessons that go beyond technical procedure. Our history is marked by opportunities to observe where errors creep in—a flexible gasket, a miscalibrated balance, a shift in room temperature. Many chemical suppliers feel distant from the real operators who weigh and dissolve the substance. We've taken a different tack. Direct communication with end-users feeds into both continuous improvement and employee training.
Staff attend workshops, engage with process engineers, and visit customer labs to understand the full journey of our compounds. Our technical team includes PhD chemists, analytical specialists, and staff with decades on both manufacturing and R&D floors. This blend means we’re not intimidated by technical troubleshooting, nor detached from the realities of bench-scale or production challenges. It helps us catch discrepancies that a reseller or broker without manufacturing understanding cannot see.
Each inquiry and feedback moment translates into constructive upgrade—sometimes in the form of updated SOPs, sometimes a tweak in drying times, and occasionally a complete overhaul of an analytical method. Document management lives alongside real scientific dialogue, free of artificial walls between producer and end-user. By owning our process documentation, we protect customer confidentiality and rapidly implement feedback.
We’ve hosted visiting scientists and interns who openly critique our protocols and suggest improvements. These real-world exchanges have delivered marked reductions in turnaround time for release and increased satisfaction among analytical users. We base our knowledge growth not on marketing, but on benchmarks drawn from everyday lab life.
We've seen researchers face setbacks after choosing cut-rate materials. What looks like a deal often turns expensive due to troubleshooting, failed runs, or time lost chasing impurities. Subtle contaminants—low-level starting materials, solvent residues, misassigned enantiomers—haunt every workflow if left unchecked. Our standpoint is shaped by seeing the cost, both human and operational, when researchers bear the brunt of hidden product quality issues.
Choosing between tartrate and other salt forms sometimes boils down to small differences in solubility, hygroscopicity, or handling. Through routine side-by-side comparisons, we note improved recovery and cleaner NMR spectra using our tartrate, reducing artifacts that complicate metabolite ID or reduce yields in follow-up syntheses. By avoiding unnecessary blends or over-processing, we encourage straightforward use, which matches the reality most scientists face—a messy, time-limited lab environment.
Our L-tartrate salt consistently demonstrates sharper melting point ranges, a more consistent powder density, and freedom from discoloration or caking over time compared to hastily manufactured alternatives. We share real data—DSC, TGA, or batch chromatograms—to guide customers, not just marketing brochures. Every inquiry opens a window into continuous improvement.
As a producer, the ethical landscape isn’t abstract. It’s clear in every decision—choice of solvents, safe disposal, traceability of each container, and staff training. We lead with traceability because regulatory and safety requirements demand it, but also because consistent material depends on honest accounting of every change. Commitment to green chemistry standards shapes our solvent choices and waste handling, not in pursuit of labels but because operators and customers expect a safe end product.
No manufacturer should overlook the human aspect of supply. We encounter real people behind every request: lead scientists under pressure, students learning core principles, managers navigating budget cycles. By exposing every aspect of manufacturing to regular auditing and open reporting, we push the industry to higher standards and minimize risks that might undermine research or patient safety.
We guide each partner through our chain of custody from raw input through final packing. Documentation isn’t just paperwork—it’s a shield for customers entering audits, a reference for troubleshooting, and a benchmark for future releases. Most customers choose us again when a quality issue arises, not just because we “fix” the batch, but because they trust the process that delivered it in the first place.
As manufacturers, we accept accountability where others push blame. Every successful release, every challenge solved on the bench or production line, builds reputation. Unlike traders, we stand behind the synthesis, the planning, and the resolution of every error. We field questions on particle size, salt form, degradation, and percent yield, because we’ve lived the process and felt its weight.
Whether you are performing an exploratory synthesis, validating an assay, or scaling a process for clinical supply, the presence of a responsible manufacturer with real knowledge shortens project timelines, eases pressure, and reduces mistakes. Documentation, technical detail, and honest conversation replace empty claims. The end result, 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine L-Tartrate, stands as a marker of hard-earned reliability in a field too often dominated by intermediaries with limited insight.
We invite new partners to experience firsthand the difference direct, engaged production can bring. Each lot signals not merely a transfer of goods, but a mutual investment in research progress, built on the practical, day-to-day experience that only real manufacturing brings.